175 related articles for article (PubMed ID: 23598480)
1. Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
Keith JA; Agostini Bigger L; Arthur PA; Maes E; Daems R
Vaccine; 2013 Apr; 31 Suppl 2():B184-93. PubMed ID: 23598480
[TBL] [Abstract][Full Text] [Related]
2. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
3. Vaccine development and deployment: opportunities and challenges in India.
Gupta SS; Nair GB; Arora NK; Ganguly NK
Vaccine; 2013 Apr; 31 Suppl 2():B43-53. PubMed ID: 23598492
[TBL] [Abstract][Full Text] [Related]
4. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
[TBL] [Abstract][Full Text] [Related]
5. Global perspectives on vaccine financing.
Berman S; Giffin RB
Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
[TBL] [Abstract][Full Text] [Related]
6. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
Mahoney R
J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
[TBL] [Abstract][Full Text] [Related]
7. Vaccine research, development, and innovation in Brazil: a translational science perspective.
Homma A; Tanuri A; Duarte AJ; Marques E; de Almeida A; Martins R; Silva-Junior JB; Possas C
Vaccine; 2013 Apr; 31 Suppl 2():B54-60. PubMed ID: 23598493
[TBL] [Abstract][Full Text] [Related]
8. Current barriers, challenges and opportunities for the development of effective STI vaccines: point of view of vaccine producers, biotech companies and funding agencies.
Dodet B
Vaccine; 2014 Mar; 32(14):1624-9. PubMed ID: 23994377
[TBL] [Abstract][Full Text] [Related]
9. Civil society organizations, the implementing partners of the Global Vaccine Action Plan.
Thacker N; Vashishtha VM; Awunyo-Akaba J; Mistry RF
Vaccine; 2013 Apr; 31 Suppl 2():B97-102. PubMed ID: 23598497
[TBL] [Abstract][Full Text] [Related]
10. Global support for new vaccine implementation in middle-income countries.
Kaddar M; Schmitt S; Makinen M; Milstien J
Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
[TBL] [Abstract][Full Text] [Related]
11. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
Shen AK
Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
[TBL] [Abstract][Full Text] [Related]
12. European Union vaccine research--an overview.
Sautter J; Olesen OF; Bray J; Draghia-Akli R
Vaccine; 2011 Sep; 29(39):6723-7. PubMed ID: 21195799
[TBL] [Abstract][Full Text] [Related]
13. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
[TBL] [Abstract][Full Text] [Related]
14. The imperative for stronger vaccine supply and logistics systems.
Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
[TBL] [Abstract][Full Text] [Related]
15. Vaccines as a global imperative--a business perspective.
Stéphenne J
Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
[TBL] [Abstract][Full Text] [Related]
16. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
Chauke-Moagi BE; Mumba M
Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
[TBL] [Abstract][Full Text] [Related]
17. Prospects for future supplies of vaccines.
Peretz SM
Rev Infect Dis; 1983; 5(3):527-30. PubMed ID: 6879009
[TBL] [Abstract][Full Text] [Related]
18. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
Shen AK; Rodewald LE; Birkhead GS
Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
[TBL] [Abstract][Full Text] [Related]
19. Straight talk with...BT Slingsby. Interviewed by Cassandra Willyard.
Slingsby BT
Nat Med; 2013 Dec; 19(12):1553. PubMed ID: 24309642
[TBL] [Abstract][Full Text] [Related]
20. A global regulatory science agenda for vaccines.
Elmgren L; Li X; Wilson C; Ball R; Wang J; Cichutek K; Pfleiderer M; Kato A; Cavaleri M; Southern J; Jivapaisarnpong T; Minor P; Griffiths E; Sohn Y; Wood D
Vaccine; 2013 Apr; 31 Suppl 2():B163-75. PubMed ID: 23598478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
